Assessment of Community-based Ivermectin Treatment Coverage for Onchocerciasis in Cameroon: The Case of Batcham Health District
EARNEST NJIH TABAH, DJAM CHEFOR ALAIN, MANFOUO TANDAH I.T, SIGNING TEDDY MARTIAL, LELE DEFFO CAROLE, BONG WOBENSO JESSICA GRACE, GUTHE KAMDEM BRICE, GAEL LARISSA KENGNE, NGUE VINYLE INES AUDE, MOMO ANOUMBO URBAIN ULRICH, NJIH BERI NKINI, NOUNI NOULA ARMAND J, KALIBE PADEU PATEKOURI, DOUANDJI SOKENG M, NGUETSE ZAMBOU LINTIA SAMIRA, TISATE LESLY KITU, DOUNTIO PIATAT XENA, TENONFO TESSE FRANKY MAXWELL, TEJIODONKENG KENGMO CAROLLE, NGNECHE KAKEU PASCALINE LAURE, STESSYE NOUATON TANKOU NYLOR, MBOTUIAH MBOLUEH HENRY, KAMSEU CEDRICK, KORIN NEH NFORBI, PROWO DONGMO STYVE U, GERMAINE NDAH ALOMBAH, KENHALE ZEBAZE LUNELLE & Kouanfack Charles · International Journal of TROPICAL DISEASE & Health · 2025
Background: Community directed treatment with ivermectin (CDTI) has led to significant reduction in the prevalence and incidence of onchocerciasis in endemic communities of Latin America and sub-Saharan Africa. At the time when the WHO targets onchocerciasis for elimination by 20...